The University of Southampton
University of Southampton Institutional Repository

The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors

The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors
The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors
Monoclonal B-cell lymphocytosis (MBL) is an asymptomatic monoclonal expansion of <5·0 × 109/l circulating CLL-phenotype B-cells. The relationship between MBL and Rai 0 CLL, as well as the impact of biological risk factors on MBL prognosis, are unknown. Out of 460 B-cell expansions with CLL-phenotype, 123 clinical MBL (cMBL) were compared to 154 Rai 0 CLL according to clinical and biological profile and outcome. cMBL had better humoral immune capacity and lower infection risk, lower prevalence of del11q22-q23/del17p13 and TP53 mutations, slower lymphocyte doubling time, and longer treatment-free survival. Also, cMBL diagnosis was a protective factor for treatment risk. Despite these favourable features, all cMBL were projected to progress, and lymphocytes <1·2 × 109/l and >3·7 × 109/l were the best thresholds predicting the lowest and highest risk of progression to CLL. Although IGHV status, CD38 and CD49d expression, and fluorescence in situ hybridization (FISH) karyotype individually predicted treatment-free survival, multivariate analysis identified the presence of +12 or del17p13 as the sole independent predictor of treatment requirement in cMBL (Hazard ratio: 5·39, 95% confidence interval 1·98–14·44, P = 0·001). Overall, these data showed that cMBL has a more favourable clinical course than Rai 0 CLL. Given that the biological profile can predict treatment requirement, stratification based on biological prognosticators may be helpful for cMBL management
monoclonal B-cell lymphocytosis, chronic lymphocytic leukaemia, prognosis, immunoglobulin genes, FISH karyotype
0007-1048
64-75
Rossi, Davide
b4b2506d-794c-4c79-8b2d-6767554fd52a
Sozzi, Elisa
e811ff23-6fe9-47ec-b052-fe8d34d1e36b
Puma, Alessia
2e3a52d1-304b-45ca-adf3-247cb01230f2
De Paoli, Lorenzo
9390755d-1a39-47e9-bc54-69f9fe914248
Rasi, Silvia
13639ced-c17f-4350-87e4-fb670cee592b
Spina, Valeria
bb72602d-3d56-424f-b169-47377aef1d10
Gozzetti, Alessandro
18591c75-cbee-444e-972e-b13dce8340e7
Tassi, Maristella
3ff312c2-d76f-4887-80a7-9219465064fb
Cencini, Emanuele
3dc5d188-96b0-4f7d-abb8-af4d22638d7e
Raspadori, Donatella
185f6866-6d10-4f86-9add-72938cea80b3
Pinto, Valeria
0bc21793-2764-4aca-9b6b-3db1466eddc0
Bertoni, Francesco
13297a2f-854a-4841-a410-d6bfca8afee8
Gattei, Valter
df828ae8-1b40-4acb-8908-5a6b3d16cf99
Lauria, Francesco
f01f163b-abcb-4aad-b952-f4356692f519
Gaidano, Gianluca
1a6a7107-107b-4891-82e0-5fedadd2f65a
Forconi, Francesco
ce9ed873-58cf-4876-bf3a-9ba1d163edc8
Rossi, Davide
b4b2506d-794c-4c79-8b2d-6767554fd52a
Sozzi, Elisa
e811ff23-6fe9-47ec-b052-fe8d34d1e36b
Puma, Alessia
2e3a52d1-304b-45ca-adf3-247cb01230f2
De Paoli, Lorenzo
9390755d-1a39-47e9-bc54-69f9fe914248
Rasi, Silvia
13639ced-c17f-4350-87e4-fb670cee592b
Spina, Valeria
bb72602d-3d56-424f-b169-47377aef1d10
Gozzetti, Alessandro
18591c75-cbee-444e-972e-b13dce8340e7
Tassi, Maristella
3ff312c2-d76f-4887-80a7-9219465064fb
Cencini, Emanuele
3dc5d188-96b0-4f7d-abb8-af4d22638d7e
Raspadori, Donatella
185f6866-6d10-4f86-9add-72938cea80b3
Pinto, Valeria
0bc21793-2764-4aca-9b6b-3db1466eddc0
Bertoni, Francesco
13297a2f-854a-4841-a410-d6bfca8afee8
Gattei, Valter
df828ae8-1b40-4acb-8908-5a6b3d16cf99
Lauria, Francesco
f01f163b-abcb-4aad-b952-f4356692f519
Gaidano, Gianluca
1a6a7107-107b-4891-82e0-5fedadd2f65a
Forconi, Francesco
ce9ed873-58cf-4876-bf3a-9ba1d163edc8

Rossi, Davide, Sozzi, Elisa, Puma, Alessia, De Paoli, Lorenzo, Rasi, Silvia, Spina, Valeria, Gozzetti, Alessandro, Tassi, Maristella, Cencini, Emanuele, Raspadori, Donatella, Pinto, Valeria, Bertoni, Francesco, Gattei, Valter, Lauria, Francesco, Gaidano, Gianluca and Forconi, Francesco (2009) The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors. British Journal of Haematology, 146 (1), 64-75. (doi:10.1111/j.1365-2141.2009.07711.x). (PMID:19438485)

Record type: Article

Abstract

Monoclonal B-cell lymphocytosis (MBL) is an asymptomatic monoclonal expansion of <5·0 × 109/l circulating CLL-phenotype B-cells. The relationship between MBL and Rai 0 CLL, as well as the impact of biological risk factors on MBL prognosis, are unknown. Out of 460 B-cell expansions with CLL-phenotype, 123 clinical MBL (cMBL) were compared to 154 Rai 0 CLL according to clinical and biological profile and outcome. cMBL had better humoral immune capacity and lower infection risk, lower prevalence of del11q22-q23/del17p13 and TP53 mutations, slower lymphocyte doubling time, and longer treatment-free survival. Also, cMBL diagnosis was a protective factor for treatment risk. Despite these favourable features, all cMBL were projected to progress, and lymphocytes <1·2 × 109/l and >3·7 × 109/l were the best thresholds predicting the lowest and highest risk of progression to CLL. Although IGHV status, CD38 and CD49d expression, and fluorescence in situ hybridization (FISH) karyotype individually predicted treatment-free survival, multivariate analysis identified the presence of +12 or del17p13 as the sole independent predictor of treatment requirement in cMBL (Hazard ratio: 5·39, 95% confidence interval 1·98–14·44, P = 0·001). Overall, these data showed that cMBL has a more favourable clinical course than Rai 0 CLL. Given that the biological profile can predict treatment requirement, stratification based on biological prognosticators may be helpful for cMBL management

This record has no associated files available for download.

More information

e-pub ahead of print date: 5 May 2009
Published date: July 2009
Keywords: monoclonal B-cell lymphocytosis, chronic lymphocytic leukaemia, prognosis, immunoglobulin genes, FISH karyotype
Organisations: Cancer Sciences

Identifiers

Local EPrints ID: 339291
URI: http://eprints.soton.ac.uk/id/eprint/339291
ISSN: 0007-1048
PURE UUID: ec40812e-e30c-4bc1-adb6-9088f058fea2
ORCID for Francesco Forconi: ORCID iD orcid.org/0000-0002-2211-1831

Catalogue record

Date deposited: 28 May 2012 13:44
Last modified: 15 Mar 2024 03:40

Export record

Altmetrics

Contributors

Author: Davide Rossi
Author: Elisa Sozzi
Author: Alessia Puma
Author: Lorenzo De Paoli
Author: Silvia Rasi
Author: Valeria Spina
Author: Alessandro Gozzetti
Author: Maristella Tassi
Author: Emanuele Cencini
Author: Donatella Raspadori
Author: Valeria Pinto
Author: Francesco Bertoni
Author: Valter Gattei
Author: Francesco Lauria
Author: Gianluca Gaidano

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×